Pfizer to acquire obesity-drug maker Metsera for $4.9 billion

World News
22-09-2025 | 07:42
High views
Share
LBCI
Share
LBCI
Whatsapp
facebook
Twitter
Messenger
telegram
print
Pfizer to acquire obesity-drug maker Metsera for $4.9 billion
Whatsapp
facebook
Twitter
Messenger
telegram
print
0min
Pfizer to acquire obesity-drug maker Metsera for $4.9 billion

U.S. pharmaceutical giant Pfizer will acquire Metsera, a maker of drugs for obesity and heart disease, for $4.9 billion, the companies said Monday.

With the purchase Pfizer aims to broaden its portfolio and enter the huge and growing market for medicines to treat obesity.

AFP

World News

Pfizer

Drug

Obesity

US

LBCI Next
France, others to recognize Palestinian state as UN week gets underway
Air raid kills 23 in Pakistan border region
LBCI Previous
Download now the LBCI mobile app
To see the latest news, the latest daily programs in Lebanon and the world
Google Play
App Store
We use
cookies
We use cookies to make
your experience on this
website better.
Accept
Learn More